Abstract:OBJECTIVE:To explore the expression of NF-E1b in colorectal cancer tissues and its association with various clinicopathological parameters and prognosis of the patients.METHODS:Clinicopathological and follow-up data of 168 colorectal cancer patients undergoing radical operation at Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute from 2005 to 2012 were retrospectively analyzed, including 96 males and 72 females, with mean age of (57.8±11.2) years. The expression of NF-E1b protein was detected in samples of 168 resected colorectal cancer tissues and 45 adjacent non-cancerous tissues by immunohistochemistry. The expression rates of NF-E1b were compared among different clinicopathological features. Moreover, the association between NF-E1b expression and prognosis was analyzed.RESULTS:The expression of NF-E1b protein located mainly in cytoplasm. Positive rate of NF-E1b expression in adjacent non-cancerous tissues was 17.8% (8/45), which was obviously lower than 67.9%(114/168) of cancer tissues with significant difference (χ(2)=36.376, P=0.000). Clinicopathological parameters analysis suggested that the expression level of NF-E1b in cancer tissues was associated with age (χ(2)=4.862, P=0.030), TNM staging (χ(2)=10.969, P=0.002), lymph node metastasis (χ(2)=7.390, P=0.008) and distal metastasis (χ(2)=17.887, P=0.000). The median follow-up time was 23(1-77) months. The overall 5-year survival of this cohort was 33.3%. Colorectal cancer patients with high levels of NF-E1b expression showed a worse overall survival compared with those with low levels of NF-E1b expression (18.4% vs. 56.6%, P=0.000). Univariate Cox regression analysis showed that tumor location (P=0.034), tumor size (P=0.003), TNM staging (P=0.000), depth of tumor invasion (P=0.009), lymph node metastasis (P=0.000), distant metastasis (P=0.000) and NF-E1b expression level (P=0.001) were associated with the prognosis of colorectal cancer patients. Multivariate Cox regression analysis revealed that tumor diameter >4 cm (HR=2.193,95% CI:1.334 to 3.603, P=0.002), distant metastasis (HR=2.064, 95% CI:1.160 to 3.672, P=0.014) and high NF-E1b expression (HR=1.994,95% CI:1.068 to 3.724, P=0.030) were independent risk factors of predicting poor prognosis of colorectal cancer patients.CONCLUSIONS:NF-E1b expression up-regulates in colorectal cancer tissues. High expression of NF-E1b is associated with poor prognosis of colorectal cancer patients. NF-E1b may serve as a potential target of the treatment for colorectal cancer.

Expression of WEE1 in colorectal cancer and its clinical significance

Upregulation of WEE1 is a Potential Prognostic Biomarker for Patients with Colorectal Cancer

High Expression of WWP1 Predicts Poor Prognosis and Associates with Tumor Progression in Human Colorectal Cancer.

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis.

[Expression of NF-E1b in Colorectal Cancer Tissues and Its Clinical Significance].

Expression of fibulin-1 predicted good prognosis in patients with colorectal cancer.

Expression and clinical significance of WIF-1 and Wnt2b in colorectal carcinoma

ERCC1 expression and its prognosis implication in colorectal cancer:a meta-analysis

High WEE1 expression is independently linked to poor survival in multiple myeloma

Expression and clinical significance of ERCC1 in colorectal cancer

Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer

Expression and Prognostic Value of WISP‐1 in Patients with Endometrial Endometrioid Adenocarcinoma

Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in Colorectal Cancer

Overexpression of Connective Tissue Growth Factor Wisp-1 in Chinese Primary Rectal Cancer Patients

Increased LEF1 Expression and Decreased Notch2 Expression Are Strong Predictors of Poor Outcomes in Colorectal Cancer Patients

Significance of expression of ECT2 in colorectal cancer

The High Expression of FOXE1 in Colorectal Cancer Predicts a Promising Prognosis: a Retrospective Study

Expressions of WWOX and CD133 in colorectal cancer and their clinical significance]

Elevated Expression of ECT2 Predicts Unfavorable Prognosis in Patients with Colorectal Cancer.

Expression of EphA1 Gene in colorectal Cancers and Its Clinical Significance